Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — coronary heart disease

By Sherry LaBeck, ND. ZRT Laboratory. It is highly likely that women aged 60 to 90 have vivid memories of the astonishing healthcare news from 2002 when the Women's Health Initiative (WHI), a comprehensive long-term national health study, was abruptly terminated earlier than expected. The initial trial results sent shockwaves through the medical community and had a profound impact on the lives of numerous women. Furthermore, this news fundamentally transformed the perception of routine menopausal hormone replacement prescriptions for years to follow. The WHI was launched in 1991 as a 15-year trial, one of the largest women’s health studies in the...

Cardiovascular disease is the leading cause of death in women, and the risk dramatically increases with menopause as estrogen levels decline. In this in-depth clinical article, Dr. Sherry LaBeck of ZRT Laboratory explains how estrogen protects the cardiovascular system through nitric oxide production, endothelial function, blood lipid regulation and anti-inflammatory mechanisms — and why the timing of estrogen replacement therapy is critical to its cardioprotective effect.